Sterling Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-30,800
Closed -$4.49M 1024
2017
Q3
$4.49M Sell
30,800
-6,623
-18% -$902K 0.04% 250
2017
Q2
$4.86M Buy
37,423
+32,638
+682% +$4M 0.05% 234
2017
Q1
$596K Buy
4,785
+1,438
+43% +$172K 0.01% 767
2016
Q4
$387K Buy
+3,347
New +$373K ﹤0.01% 811
2016
Q3
Sell
-2,462
Closed -$243K 1020
2016
Q2
$243K Buy
+2,462
New +$255K ﹤0.01% 854
2016
Q1
Sell
-7,060
Closed -$845K 1061
2015
Q4
$845K Buy
7,060
+2,026
+40% +$234K 0.01% 578
2015
Q3
$544K Sell
5,034
-4,613
-48% -$572K ﹤0.01% 702
2015
Q2
$1.12M Buy
9,647
+6,193
+179% +$708K 0.01% 426
2015
Q1
$398K Sell
3,454
-1,692
-33% -$202K ﹤0.01% 747
2014
Q4
$576K Buy
5,146
+2,657
+107% +$280K 0.01% 749
2014
Q3
$236K Buy
+2,489
New +$225K ﹤0.01% 854

Other funds holding CELG

Sterling Capital Management's CELG Position: Q4 2017 in Review

Sterling Capital Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 30,800 shares — an estimated $4.49M sold.

Sterling Capital Management first reported a position in CELG in Q3 2014 and held it in 11 quarters. The position peaked at $4.86M in Q2 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Sterling Capital Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Sterling Capital Management sold 30,800 Celgene Corp shares in Q4 2017, an estimated $4.49M.
  • Sterling Capital Management first reported a position in Celgene Corp in Q3 2014 and held it in 11 quarters.
  • Sterling Capital Management's Celgene Corp position peaked at $4.86M in Q2 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Sterling Capital Management's 13F filing for Q4 2017, filed 15 Feb 2018.